Related Experiment Video
Updated: Nov 25, 2025
07:11
Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
3.1K
[Left ventricular non-compaction : diagnosis and management].
F Damas1, A Ancion2, J Tridetti1
1Service de Cardiologie, CHU Liège, Belgique.
Revue Medicale De Liege
|December 17, 2020
Summary
Isolated left ventricular non-compaction (LVNC) is a congenital heart disorder. This review clarifies diagnostic criteria to improve management of LVNC and its associated risks.
Area of Science:
- Cardiology
- Genetics
- Medical Imaging
Background:
- Isolated left ventricular non-compaction (LVNC) is a rare congenital cardiomyopathy.
- Characterized by prominent myocardial trabeculations and deep intertrabecular recesses.
- Current diagnostic criteria lack strong evidence-based support, complicating diagnosis, especially in atypical forms.
Purpose of the Study:
- To optimize understanding and management of LVNC.
- To review and emphasize established diagnostic criteria for LVNC.
- To guide clinicians in diagnosing and managing patients with this condition.
Main Methods:
- Review of existing literature on LVNC diagnosis and management.
- Analysis of echocardiography and cardiac magnetic resonance findings.
- Discussion of clinical manifestations, genetic factors, and treatment strategies.
Main Results:
- LVNC diagnosis relies on imaging but lacks definitive evidence-based criteria.
- Affected individuals face risks of heart failure, arrhythmias, and cardio-embolism.
- Familial LVNC necessitates genetic counseling.
Conclusions:
- Standardizing diagnostic criteria is crucial for effective LVNC management.
- Early and accurate diagnosis improves patient outcomes.
- Further research is needed to establish robust diagnostic guidelines.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
193
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
193
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
173
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
173
01:29Cardiomyopathy V: Interprofessional Care
128
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
128
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
250
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
250
01:30Heart Failure V: Medical Management
96
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
96
01:30Heart Failure IV: Classification and Diagnostic Evaluation
144
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
144